The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Open accessAbstract
Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli. They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics. Herein, we demonstrate that small-molecule IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of auto-ubiquitination activity and rapid proteasomal degradation of c-IAPs. The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis. Additionally, the c-IAP proteins were found to function as regulators of NF-kappaB signaling. Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degradation of NIK, the central ser/thr kinase in the noncanonical NF-kappaB pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This switch between target substrate ubiquitylation and autoubiquitylation following changes in binding partner might be a general feature of RING E3 ligases, since ligand binding to IAP (a member of the RING E3 inhibitor of apoptosis proteins) stimulates IAP auto-destruction [43].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [43]
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., HAVEMAN, J., & Chris van, B. R. E. E. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,202
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I. I., Oliver, H., Lutter, M. L., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,577
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,469
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
TNF-R1 Signaling: A Beautiful Pathway
Chen, G., & Goeddel, D. V. (2002) · Science · doi:10.1126/science.1071924 · Cited by 1,930
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,000
Necroptosis: A new way of dying?
Hanson, B. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1210732 · Cited by 93
Miura, K., Fujibuchi, W., Ishida, K., Naitoh, T., Ogawa, H., Ando, T., Yazaki, N., Watanabe, K., Haneda, S., Shibata, C., et al. (2011) · Surgery Today · doi:10.1007/s00595-010-4390-1 · Cited by 86
5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma
Coupienne, I., Fettweis, G., Rubio, N., Agostinis, P., & Piette, J. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05213f · Cited by 91
Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
Lim, B., Greer, Y. E., Lipkowitz, S., & Takebe, N. (2019) · Cancers · doi:10.3390/cancers11081087 · Cited by 83
TWEAK and cIAP1 Regulate Myoblast Fusion Through the Noncanonical NF-κB Signaling Pathway
Enwere, E. K., Holbrook, J., Mrad, R. L., Vineham, J., Timusk, K., Sivaraj, B., Isaac, M. B., Uehling, D., Al‐awar, R., LaCasse, E. C., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2003086 · Cited by 85
Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils
Wicki, S., Gurzeler, U., Wong, W. W.-L., Jost, P. J., Bachmann, D., & Kaufmann, T. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.311 · Cited by 85
PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF
Kearney, C. J., Lalaoui, N., Freeman, A. J., Ramsbottom, K. M., Silke, J., & Oliaro, J. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.94 · Cited by 83
Chromik, J., Safferthal, C., Serve, H. L., & Fulda, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.018 · Cited by 87
Necrosis-dependent and independent signaling of the RIP kinases in inflammation
Moriwaki, K., & Chan, F. K.-M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.013 · Cited by 84
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
Karl, I., Jossberger-Werner, M., Schmidt, N., Horn, S., Goebeler, M., Leverkus, M., Wajant, H., & Giner, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.404 · Cited by 90
Dai, Y., Lawrence, T. S., & Xu, L. (2009) · PubMed Central · Cited by 86
Kavanagh, E. T., Rodhe, J., Burguillos, M. Á., Venero, J. L., & Joseph, B. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.514 · Cited by 82
Inhibitor of apoptosis proteins as intracellular signaling intermediates
Kocab, A. J., & Duckett, C. S. (2015) · FEBS Journal · doi:10.1111/febs.13554 · Cited by 89
“These Smac mimetics (SMs), which are also known as IAP antagonists, similarly bind the IAPs and induce their degradation [56, 63, 64].”
BackgroundInfluentialKilling by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System
Abbas, R., & Larisch, S. (2021) · Cells · doi:10.3390/cells10123465 · Cited by 91
Afonina, I. S., Elton, L., Carpentier, I., & Beyaert, R. (2015) · FEBS Journal · doi:10.1111/febs.13325 · Cited by 84
Yang, X.-H., Feng, Z., Yan, M., Hanada, S., Zuo, H., Yang, C., Han, Z.-G., Guo, W., Chen, W., & Zhang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031601 · Cited by 81
Small-molecule pan-IAP antagonists: a patent review
Flygare, J. A., & Fairbrother, W. J. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903567077 · Cited by 80
“IAP proteins also have been associated with activation of signal transduction pathways associated with malignancy, including NF-kB (Figure 1), JNK1, TGF-b, Myc, PI3K/Akt and the MAPK cascade [29-40].”
Paul, A., Edwards, J., Pepper, C. J., & Mackay, S. P. (2018) · Cells · doi:10.3390/cells7100176 · Cited by 85
Small molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79
SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells
Campbell, G. R., Bruckman, R. S., Chu, Y.-L., Trout, R. N., & Spector, S. A. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.09.007 · Cited by 82
“The interaction of SM with XIAP leads to caspase activation (Gao et al., 2007), while the binding of SM to BIRC2 and BIRC3 enhances their E3 ligase activity, promoting their autoubiquitination and proteasomal degradation with subsequent cell death (Bertrand et al., 2008; Varfolomeev et al., 2007).”
BackgroundRegulation of cell death by the ubiquitin–proteasome system
Bader, M., & Steller, H. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.09.005 · Cited by 81
Asymmetric Recruitment of cIAPs by TRAF2
Mace, P. D., Smits, C., Vaux, D. L., Silke, J., & Day, C. L. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.055 · Cited by 79
Targeting NF-κB for colorectal cancer
Sakamoto, K., & Maeda, S. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003769903 · Cited by 81
“An IAP antagonist induces degradation of cIAP1 and cIAP2, resulting in the promotion of TNF-a-mediated apoptosis [78].”
Greenfeld, H., Takasaki, K., Walsh, M. J., Ersing, I., Bernhardt, K., Ma, Y., Fu, B., Ashbaugh, C. W., Cabo, J., Mollo, S. B., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004890 · Cited by 77
Regulation of Innate and Adaptive Antitumor Immunity by IAP Antagonists
Dougan, S. K., & Dougan, M. L. (2018) · Immunotherapy · doi:10.2217/imt-2017-0185 · Cited by 80
Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death
Kist, M., Kömüves, L. G., Goncharov, T., Dugger, D. L., Yu, C., Roose‐Girma, M., Newton, K., Webster, J. D., & Vucic, D. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00629-3 · Cited by 79
“[40]) enhanced TNF- or TZ-induced cell death in WT, but not K376R MEFs (Fig.”
BackgroundLecis, D., Drago, C., Manzoni, L., Seneci, P., Scolastico, C., Mastrangelo, E., Bolognesi, M., Anichini, A., Kashkar, H., Walczak, H., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605687 · Cited by 77
“Intriguingly, they were also found to target other members of the IAP family, especially cIAP1 and cIAP2 (Varfolomeev et al, 2007; Vince et al, 2007; Galbán et al, 2009).”
BackgroundInfluentialItoh, Y., Ishikawa, M., Kitaguchi, R., Okuhira, K., Naito, M., & Hashimoto, Y. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.134 · Cited by 78
Dixon, L. K., Sánchez‐Cordón, P. J., Galindo, I., & Alonso, C. (2017) · Viruses · doi:10.3390/v9090241 · Cited by 77
“It was later established that IAPs bind to TRAFs (Figure 1) via their BIR1 domains [34,35].”
BackgroundSmac mimetics as IAP antagonists
Fulda, S. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.12.005 · Cited by 81
A NIK–SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB
Liu, Z., Mar, K. B., Hanners, N. W., Perelman, S. S., Kanchwala, M., Xing, C., Schoggins, J. W., & Alto, N. M. (2019) · Nature · doi:10.1038/s41586-019-1041-6 · Cited by 79
Mitochondrial control of innate immune responses
Chen, S., Liao, Z., & Xu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166214 · Cited by 87
“This phenotype has also been observed with SMAC-mimetic compounds treatment (88, 89), but an exception exists.”
MethodBoenig, G. D. L., Bowman, K. K., Feng, J. A., Crawford, T. D., Everett, C., Franke, Y., Oh, A., Stanley, M. S., Staben, S. T., Starovasnik, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.07.013 · Cited by 76
“In the absence of pathway activation, NIK protein is regulated by constitutive TRAF3/cIAP-mediated ubiquitin-triggered degradation (Varfolomeev et al., 2007; Zarnegar et al., 2008a, 2008b).”
BackgroundDown-regulation of c-FLIP Enhances Death of Cancer Cells by Smac Mimetic Compound
Cheung, H. H., Mahoney, D. J., LaCasse, E. C., & Korneluk, R. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1794 · Cited by 75
Coupienne, I., Bontems, S., Dewaele, M., Rubio, N., Habraken, Y., Fulda, S., Agostinis, P., & Piette, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.015 · Cited by 83
Smac Mimetics to Therapeutically Target IAP Proteins in Cancer
Fulda, S. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.004 · Cited by 78
Quantitative and Dynamic Catalogs of Proteins Released during Apoptotic and Necroptotic Cell Death
Tanzer, M. C., Frauenstein, A., Stafford, C. A., Phulphagar, K. M., Mann, M., & Meissner, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.079 · Cited by 79
Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways
van Dijk, M., McCormick, A., Sessler, T., Afshin Samali, A., & Szegezdi, É. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.214 · Cited by 74
Sanjo, H., Zajonc, D. M., Braden, R. L., Norris, P. S., & Ware, C. F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105874 · Cited by 74
Li, Y., Kong, Y., Zhou, Z., Chen, H.-M., Wang, Z., Hsieh, Y.-C., Zhao, D. H., Zhi, X., Huang, J., Zhang, J., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.464 · Cited by 74
The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling
Vandenabeele, P., & Bertrand, M. J. M. (2012) · Nature reviews. Immunology · doi:10.1038/nri3325 · Cited by 75
Yu, X., Deng, Q., Li, W., Xiao, L., Luo, X., Liu, X., Yang, L., Peng, S., Ding, Z., Feng, T., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3038 · Cited by 76
“Both the canonical and non-canonical NF-κB pathways have been reported to participate in autocrine production of TNFα in cancer cells [20, 21, 36].”
InfluentialTchoghandjian, A., Jennewein, C., Eckhardt, I., Rajalingam, K., & Fulda, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.70 · Cited by 75
“Of note, TNFa/TNFR1 autocrine/ paracrine signaling has been implicated to mediate apoptosis of Smac mimetic at lethal concentrations.(14,15) Thus, Smac mimetic may differentially engage non-apoptotic and apoptotic TNFa/TNFR1-mediated events in a context-dependent manner.”
InfluentialPandya, R. K., Partridge, J. R., Love, K. R., Schwartz, T., & Ploegh, H. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051805 · Cited by 73
Etemadi, N., Holien, J. K., Chau, D., Dewson, G., Murphy, J. M., Alexander, W. S., Parker, M. W., Silke, J., & Nachbur, U. (2013) · FEBS Journal · doi:10.1111/febs.12419 · Cited by 73
Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome
Moriwaki, K., & Chan, F. K.-M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700997 · Cited by 74
“However, the SMAC mimetic BV6, which induces IAP degradation (34), did not alter MG132-induced RIPK3 ubiquitination or cell death (Fig.”
BackgroundTranscriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer
Deka, K., & Li, Y. (2023) · Cells · doi:10.3390/cells12050788 · Cited by 75
To fight or die — inhibitor of apoptosis proteins at the crossroad of innate immunity and death
Lopez, J. S., & Meier, P. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.025 · Cited by 71
Dai, Y., Liu, M., Tang, W., Li, Y., Lian, J., Lawrence, T. S., & Xu, L. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-392 · Cited by 72
Ward, G. A., Lewis, E. J., Ahn, J. S., Johnson, C. N., Lyons, J. F., Martins, V., Munck, J. M., Rich, S. J., Smyth, T., Thompson, N. T., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0848 · Cited by 78
“This leads to rapid autoubiquitination and proteasomal degradation of cIAP1/2 (14).”
Berger, R. S., Jennewein, C., Marschall, V., Karl, S., Cristofanon, S., Wagner, L., Vellanki, S. H., Hehlgans, S., Rödel, F., Debatin, K., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0218 · Cited by 71
Linear ubiquitination signals in adaptive immune responses
Ikeda, F. (2015) · Immunological Reviews · doi:10.1111/imr.12300 · Cited by 71
Carter, B. Z., Mak, P. Y., Mak, D. H. F., Shi, Y., Qiu, Y., Bogenberger, J. M., Mu, H., Tibes, R., Yao, H., Coombes, K. R., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt440 · Cited by 70
“03 for birinapant plus TRIAL under standard, MSC co-culture, hypoxia, or MSC co-culture and hypoxia, respectively) (Figure 2C), in agreement with the literature (13,17,18,35).”
Liu, Y., Song, L., Sun, Y., Liu, T., Hou, F., & Liu, X. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.02.004 · Cited by 70
“We then detected the expression of IAP1, which is known to be an important 386 factor in TNF-mediated induction of NF-κB signaling (Petersen et al. 2007; 387 Varfolomeev et al. 2007), and found IAP1 was significantly decreased both in V. 388 anguillarum and M. lysodeikticu infection groups.”
BackgroundRSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death
Dächert, J., Schoeneberger, H., Rohde, K., & Fulda, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11687 · Cited by 73
Monomeric Targeted Protein Degraders
Hanan, E. J., Liang, J., Wang, X., Blake, R. A., Blaquiere, N., & Staben, S. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00093 · Cited by 69
Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation
Zhang, J., Webster, J. D., Dugger, D. L., Goncharov, T., Roose‐Girma, M., Hung, J., Kwon, Y. C., Vucic, D., Newton, K., & Dixit, V. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.111 · Cited by 71
Graber, T. E., Baird, S. D., Kao, P. N., Mathews, M. B., & Holčı́k, M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.164 · Cited by 69
“Cellular inhibitor of apoptosis protein 1 (cIAP1) is a critical regulator of cell survival and nuclear factor-kB (NF-kB) signaling.(16,17) We and others have shown that the expression”
Human T-Cell Lymphotropic Virus: A Model of NF-κB-Associated Tumorigenesis
Qu, Z., & Xiao, G. (2011) · Viruses · doi:10.3390/v3060714 · Cited by 70
Necroptotic signaling in adaptive and innate immunity
Lu, J. V., Chen, H. C., & Walsh, C. M. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.07.003 · Cited by 71
Targeting cell death signalling in cancer: minimising ‘Collateral damage’
Fox, J. L., & MacFarlane, M. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.111 · Cited by 69
Grabinger, T., Bode, K. J., Demgenski, J., Seitz, C., Delgado, M. E., Kostadinova, F. I., Reinhold, C., Etemadi, N., Wilhelm, S., Schweinlin, M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.019 · Cited by 66
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
Freeman, A. J., Kearney, C. J., Silke, J., & Oliaro, J. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.10.003 · Cited by 69
Lee, E.-W., Seong, D., Seo, J. H., Jeong, M., Lee, H.-K., & Song, J. J. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.234 · Cited by 68
Hofmann, J., Mair, F., Greter, M., Schmidt‐Supprian, M., & Becher, B. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110128 · Cited by 67
Safferthal, C., Rohde, K., & Fulda, S. (2016) · Oncogene · doi:10.1038/onc.2016.310 · Cited by 68
Murphy, J. M., & Silke, J. (2014) · EMBO Reports · doi:10.1002/embr.201337970 · Cited by 69
“An interesting speculation is whether IAPs constitutively inhibit complex 2 formation (in much the same way they target NIK kinase [13,14]) and that one of the functions of TNFSF DL signalling is to reassign them.”
Eytan, D. F., Snow, G. E., Carlson, S. G., Derakhshan, A., Saleh, A., Schiltz, S., Cheng, H. W., Mohan, S., Cornelius, S., Coupar, J. F., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3317 · Cited by 72
“Binding of TNFα, TRAIL or other death agonists to their receptors typically leads to cell death via FADD through the activation of caspase-8 and induction of apoptosis, or alternatively, activation of RIP kinase 1 (RIPK1), MLKL, and induction of necroptosis (5-10).”
Design of Small-Molecule Smac Mimetics as IAP Antagonists
Wang, S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_111 · Cited by 66
Cheung, H. H., Plenchette, S., Kern, C. J., Mahoney, D. J., & Korneluk, R. G. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0107 · Cited by 67
Engel, K. C., Rudelius, M., Slawska, J., Jacobs, L., Abhari, B. A., Altmann, B., Kurutz, J., Rathakrishnan, A., Fernández‐Sáiz, V., Brunner, A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506047 · Cited by 67
“SMAC mimetics have been shown to induce degradation of cIAP1/2 (Li et al, 2004; Varfolomeev et al, 2007; Vince et al, 2007).”
TNFR signalling and its clinical implications
Tseng, W.-Y., Huang, Y.-S., Lin, H., Luo, S., McCann, F. E., McNamee, K., Clanchy, F. I. L., & Williams, R. O. (2016) · Cytokine · doi:10.1016/j.cyto.2016.08.027 · Cited by 71
Coleman, K. G., & Crews, C. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050430 · Cited by 72
“Therefore, alternative SNIPER(CRABP) molecules were generated in which the cIAP1selective ligand MeBS was replaced with the pan-IAP antagonist MV1 (Varfolomeev et al. 2007) to generate SNIPER(CRABP)-6 (Itoh et al.”
MethodTegowski, M., & Baldwin, A. S. (2018) · Biomedicines · doi:10.3390/biomedicines6020066 · Cited by 73
Löder, S., Fakler, M., Schoeneberger, H., Cristofanon, S., Leibacher, J., Vanlangenakker, N., Bertrand, M. J. M., Vandenabeele, P., Jeremias, I., Debatin, K., et al. (2011) · Leukemia · doi:10.1038/leu.2011.353 · Cited by 68
Brightbill, H. D., Jackman, J. K., Suto, E., Kennedy, H., Jones, C., Chalasani, S., Lin, Z., Tam, L., Roose-Girma, M., Balázs, M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401514 · Cited by 65
Estornes, Y., Aguileta, M., Dubuisson, C., Keyser, J. D., Goossens, V., Kersse, K., Samali, A., Vandenabeele, P., & Bertrand, M. J. M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.523 · Cited by 66
E3 Ubiquitin Ligase HOIP Attenuates Apoptotic Cell Death Induced by Cisplatin
MacKay, C., Carroll, E., Ibrahim, A. F. M., Garg, A. K., Inman, G. J., Hay, R. T., & Alpi, A. F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2131 · Cited by 65
Lü, J., McEachern, D., Sun, H., Bai, L., Peng, Y., Qiu, S., Miller, R. S., Liao, J., Han, Y., Liu, M., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0864 · Cited by 66
Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
Siegmund, D., Kums, J., Ehrenschwender, M., & Wajant, H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.285 · Cited by 69
“In the case of cIAP1 and cIAP2, this results in dimerization-induced K48-linked auto-ubiquitination and subsequent proteasomal degradation.(25) cIAP1 expression levels were severely reduced in BV6-treated macrophages irrespective of zVADfmk or necrostatin-1 treatment, while there was no effect on TRAF2 (Figure 4a).”
Anti-Apoptotic Genes in the Survival of Monocytic Cells During Infection
Busca, A., Saxena, M., Kryworuchko, M., & Kumar, A. (2009) · Current Genomics · doi:10.2174/138920209788920967 · Cited by 64
RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development
Anderton, H., Bandala‐Sanchez, E., Simpson, D. S., Rickard, J. A., Ng, A. P., Rago, L. D., Hall, C. M., Vince, J. E., Silke, J., Liccardi, G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0166-8 · Cited by 65
Fingas, C. D., Blechacz, B. R. A., Smoot, R. L., Guicciardi, M. E., Mott, J. L., Bronk, S. F., Werneburg, N. W., Sirica, A. E., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23729 · Cited by 64
The Ripoptosome: Death Decision in the Cytosol
Bertrand, M. J. M., & Vandenabeele, P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.007 · Cited by 64
“Smac mimetics (SM) induce autoubiquitination and degradation of cIAPs (Bertrand et al., 2008; Varfolomeev et al., 2007; Vince et al., 2007), but the mechanism for etoposide-induced repression of IAPs remains uncharacterized.”
BackgroundInhibitor of apoptosis proteins in hematological malignancies
Fulda, S. (2008) · Leukemia · doi:10.1038/leu.2008.329 · Cited by 67
Nuclear factor κB–inducing kinase activation as a mechanism of pancreatic β cell failure in obesity
Malle, E. K., Zammit, N. W., Walters, S. N., Koay, Y. C., Wu, J., Tan, B. M., Villanueva, J. E., Brink, R. A., Loudovaris, T., Cantley, J., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150218 · Cited by 65
Cell death-based treatment of glioblastoma
Fulda, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0021-8 · Cited by 65
The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
Michie, J., Kearney, C. J., Hawkins, E. D., Silke, J., & Oliaro, J. (2020) · Cells · doi:10.3390/cells9010207 · Cited by 67
“The cellular IAPs (cIAPs) also have a critical role in the regulation of NF-κB-inducing kinase (NIK) through K-48 ubiquitylation; a process that leads to its continuous degradation and therefore low-level expression [26,27].”
BackgroundInterferons Transcriptionally Up-Regulate MLKL Expression in Cancer Cells
Knuth, A.-K., Rösler, S., Schenk, B., Kowald, L., van Wijk, S. J. L., & Fulda, S. (2019) · Neoplasia · doi:10.1016/j.neo.2018.11.002 · Cited by 63
The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription
Simon, P. S., Sharman, S. K., Lu, C., Yang, D., Paschall, A. V., Tulachan, S., & Liu, K. (2015) · BMC Cancer · doi:10.1186/s12885-015-1808-6 · Cited by 63
Roehle, K., Li, Q., Ventre, K. S., Heid, D., Ali, L. R., Lenehan, P. J., Heckler, M., Crowley, S. J., Stump, C. T., Ro, G., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf5058 · Cited by 63
XIAP impairs Smac release from the mitochondria during apoptosis
Flanagan, L., Sebastià, J., Tuffy, L. P., Spring, A., Lichawska-Cieślar, A., Devocelle, M. C., Prehn, J. H. M., & Rehm, M. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.26 · Cited by 63
Chiu, Y., Zhao, M., & Chen, Z. J. (2009) · Chemical Reviews · doi:10.1021/cr800554j · Cited by 65
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy
Mohana‐Kumaran, N., Hill, D. S., Allen, J. D., & Haass, N. K. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12242 · Cited by 63
Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings
Ball, B. J., Zeidan, A. M., Gore, S. D., & Prébet, T. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1228927 · Cited by 64
Castanedo, G. M., Blaquière, N., Beresini, M. H., Bravo, B. J., Brightbill, H. D., Chen, J., Cui, H., Eigenbrot, C. W., Everett, C., Feng, J. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01363 · Cited by 66
Enwere, E. K., LaCasse, E. C., Adam, N., & Korneluk, R. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00034 · Cited by 65
Noncanonical NF-κB Signaling Is Limited by Classical NF-κB Activity
Gray, C. M., Remouchamps, C., McCorkell, K. A., Solt, L. A., Dejardin, E., Orange, J. S., & May, M. J. (2014) · Science Signaling · doi:10.1126/scisignal.2004557 · Cited by 62
Chen, K., Zhou, X., Jiang, W., Wu, P., Liu, Y., Jiang, J., Kuang, S., Tang, L., Tang, W., Zhang, Y., et al. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.12.060 · Cited by 61
Fulda, S. (2014) · Leukemia · doi:10.1038/leu.2014.56 · Cited by 63
Metadata
- Authors
- Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., Flygare, J. A., Fairbrother, W. J., Deshayes, K., Dixit, V. M., & Vucic, D.
- Affiliations
- Genentech (US)
- Corresponding author
- Dixit, Vishva M.
- Vucic, Domagoj
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 131
- Issue
- 4
- Pages
- 669-681
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2064299413
- Cited by
- 1,218
- References
- 51
- Citations by year
- 2026: 28 · 2025: 24 · 2024: 39 · 2023: 45 · 2022: 41 · 2021: 60 · 2020: 59 · 2019: 54 · 2018: 69 · 2017: 64 · 2016: 78 · 2015: 80 · 2014: 100 · 2013: 78 · 2012: 71
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- inhibitor of apoptosis proteins, IAP antagonists, cIAP1, cIAP2, autoubiquitination, proteasomal degradation, NF-κB signaling, non-canonical NF-κB signaling, NIK, TNF signaling, apoptosis, cancer therapeutics
- MeSH terms
- Animals, Cell Line, Humans, Neoplasms, Tumor Necrosis Factor-alpha, Molecular Structure, Signal Transduction, NF-kappa B, Apoptosis, Protein Structure, Tertiary, Polyubiquitin, Proteasome Endopeptidase Complex, Inhibitor of Apoptosis Proteins, Mice, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review